Metformin-containing Drugs: Drug Safety Communication - Revised Warnings for Certain Patients With Reduced Kidney Function
FDA requiring changes to metformin labeling to provide specific recommendations on use in patients with mild to moderate kidney impairment. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 8, 2016 Category: American Health Source Type: alerts
Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
FDA adding new Warnings and Precautions to the labels of medicines that contain saxagliptin or alogliptin to inform of the potential increased risk of heart failure. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 5, 2016 Category: American Health Source Type: alerts
Continuum Labs LGD-4033 by Invisiblu International: Recall - Investigational Drug Not Approved for Use
Product found to contain LGD-4033 Ligandrol, an investigational drug not approved for use. The risks of using this product are unknown. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 5, 2016 Category: American Health Source Type: alerts
Urogynecologic Surgical Mesh Implants by Boston Scientific: Notification – Potential for Counterfeit Raw Material
FDA not recommending removal of this device, since the available data do not suggest any decreased benefit. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 1, 2016 Category: American Health Source Type: alerts
Interference between Computed Tomography (CT) and Electronic Medical Devices: Notification – Current Understanding of Potential Risk
Information about a rare and preventable type of interference between CT and electronic medical devices. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 1, 2016 Category: American Health Source Type: alerts
Sterile Drug Products by Medaus Pharmacy: FDA Alert - Lack of Sterility Assurance
Administration of a non-sterile product, intended to be sterile, may result in serious and potentially life-threatening infections or death. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - April 1, 2016 Category: American Health Source Type: alerts
5 Percent Dextrose Injection USP in PAB Container by B. Braun Medical: Recall - Leakage and/or Particulate Matter
Intravenous administration of a non-sterile product can result in serious infections that may be life-threatening. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 29, 2016 Category: American Health Source Type: alerts
OxySure Portable Emergency Oxygen System, Model 615 by OxySure Therapeutics, Inc: FDA Safety Communication - Do Not Use
Patients and other users of the affected device are at risk for serious adverse health consequences, such as burns and death. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 29, 2016 Category: American Health Source Type: alerts
Compounded Products by Reliable Drug Pharmacy: Recall - Potential for Mislabeling and Lack of Quality Assurance
Stop using recalled product immediately and arrange for the return of unused product. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 28, 2016 Category: American Health Source Type: alerts
Best Bentonite Clay by Best Bentonite: FDA Alert - Risk of Lead Poisoning
Exposure to lead can cause serious damage to the central nervous system, kidneys, and immune system. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 23, 2016 Category: American Health Source Type: alerts
NOW Health Group Dietary Supplements: Recall - Mislabeling
People with an allergy or severe sensitivity to soy risk serious or life-threatening allergic reaction if they consume these products. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 22, 2016 Category: American Health Source Type: alerts
Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
FDA is warning about several safety issues with the class of opioid pain medicines, including serotonin syndrome, adrenal insufficiency, and androgen deficiency. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 22, 2016 Category: American Health Source Type: alerts
Sodium Bicarbonate Injection, USP by Hospira: Recall - Particulate Matter
Administration of product with particulates may result in localized inflammation, allergic reaction including anaphylaxis, granuloma formation, microembolic effects, or delay of therapy. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 21, 2016 Category: American Health Source Type: alerts
GlideScope Titanium Single-Use Video Laryngoscope by Verathon: Class I Recall - Potential Video Feed Disruption
Disrupted or unstable video image may lead to delayed tracheal tube insertion, intubation failure, and other serious adverse health consequences, including hypoxemia, end organ damage, or death. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 18, 2016 Category: American Health Source Type: alerts
Eye Drops: FDA Statement - Potential Risk of Loose Safety Seals
A loose safety seal or ring presents a safety risk as it may cause eye injuries. (Source: FDA MedWatch Safety Alert)
Source: FDA MedWatch Safety Alert - March 15, 2016 Category: American Health Source Type: alerts
